Physician profile
Subramoni Sundaram
NPI 1811075005
$1,771.41
in general payments reported to CMS, 2019-2025
20 companies · $13.60 in 2025
The $13.60 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $427 · 2020: $43.67 · 2021: $115 · 2022: $292 · 2023: $289 · 2024: $591 · 2025: $13.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $894.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $893.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $283.92 | 2019-2024 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $262.96 | 2019-2024 | Lokelma, Farxiga, Breztri |
| Bayer Healthcare Pharmaceuticals INC. | $248.38 | 2021-2024 | |
| Lilly USA, LLC | $150.73 | 2021-2025 | Jardiance, Mounjaro |
| Otsuka America Pharmaceutical, INC. | $127.48 | 2019-2024 | Rexulti |
| Novartis Pharmaceuticals Corporation | $116.27 | 2022-2023 | |
| Corcept Therapeutics | $99.09 | 2024 | Korlym |
| Pfizer INC. | $78.87 | 2022-2024 | |
| Amgen INC. | $70.32 | 2019-2023 | Repatha, Otezla |
| Merck Sharp & Dohme LLC | $55.18 | 2019-2022 | |
| Opko Pharmaceuticals, LLC | $42.65 | 2019-2020 | |
| Amarin Pharma, INC. | $38.81 | 2021 | |
| Allergan, INC. | $36.33 | 2019-2020 | |
| Xeris Pharmaceuticals, INC. | $33.70 | 2023-2024 | Gvoke Hypopen |
| Bausch Health US, LLC | $31.96 | 2019-2024 | Aplenzin, Wellbutrin |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $28.00 | 2019-2022 | |
| Exact Sciences Corporation | $24.40 | 2023 | Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $14.74 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.85 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $13.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Subramoni Sundaram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.